申请人:Syntex (U.S.A.) Inc.
公开号:US04419368A1
公开(公告)日:1983-12-06
Psoriasis in mammals is relieved by topically administering substituted naphthoquinone of the formula: ##STR1## wherein: R.sup.3 is halo, linear or branched alkoxy of one to eighteen carbon atoms or --S(O).sub.n R wherein: n is 0, 1 or 2; and R is a alkyl of one to eighteen carbon atoms, alkoxycarbonylalkyl, optionally substituted phenyl, optionally substituted phenylalkyl or optionally substituted heterocyclic aryl and the pharmaceutically acceptable salts of said heterocyclic aryl.
在哺乳动物中,通过局部给予以下结构的取代萘醌可缓解牛皮癣:##STR1## 其中:R.sup.3是卤素,一至十八个碳原子的直链或支链烷氧基,或--S(O).sub.n R其中:n为0、1或2;R是一至十八个碳原子的烷基,烷氧羰基烷基,可选择地取代的苯基,可选择地取代的苯基烷基或可选择地取代的杂环芳基,以及所述杂环芳基的药用可接受盐。